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K. l 1 A fluorescent lectin-agarose bead immunoassay for a pancreatic 
autoantigen involved in Crohn's disease 
W I E B K E R Ö G E N E R , E. H O R B A C H , D O R I S KAISER, W . STÖCKER, M . O T T E , and P. C. SCRIBA 
Pancreatic autoantigen (PAg) which is recognized by many sera of patients with Crohn's 
disease (CD) could up to now only be identified by a neutralization technique, in which the 
capacity of samples to extinguish a specific immunofluorescence reaction of CD-sera wi th 
human pancreatic tissue sections was recorded. However, the neutralizing efficacy of crude 
duodenal juice or homogenized pancreas could not be evaluated, since activated proteinases 
digested the tissue sections. Solid phase immunotests, based on direct binding of PAg to 
plastic surfaces gave inconsistent results, possibly depending on the low affinity of PAg to 
the materials used. We have found out that PAg binds to soybean agglutinin (SBA) which is 
known to react wi th N-acetylgalactosamine. Thus, it was possible to develop a new assay for 
the detection of PAg: Samples were diluted in microtiter plates (50 ud per well) and incubated 
for 15 min with 10 u,l of a 50% suspension of SBA-coated agarose beads (Carrion, Wiesba-
den). 50 uJ of 1 % ovalbumine were added. After washing in PBS, beads were further 
incubated wi th 50 ul of H L - 1 (monoclonal antibody against PAg; for 30 min, washed again 
and stained for 30 min wi th FITC-labelled goat anti-mouse IgG. Results were read wi th a 
fluorescence microscope. Positive beads exhibited a bright fluorescence. O f 200 samples 
which were identified to contain PAg as determined by the neutralization test, each was 
clearly positive in the lectin agarose bead immunoassay. Semiquantification was possible by 
titration of samples in twofold dilutions, which resulted in a clear cut end point. PAg could 
easily be detected in homogenized pancreas and contents of the bowel. The new assay for 
PAg was simple to perform, easy to read and seems to be more widely applicable than the 
neutralization test. 
